Is heterotopic ossification getting nervous?: The role of the peripheral nervous system in heterotopic ossification

Bone. 2018 Apr:109:22-27. doi: 10.1016/j.bone.2017.07.016. Epub 2017 Jul 15.

Abstract

Heterotopic ossification (HO), or de novo bone formation in soft tissue, is often observed following traumatic injury. Recent studies suggest that peripheral nerves may play a key functional role in this process. The results supporting a neurological basis for HO are examined in this article. Evidence supports the fact that BMPs released from bone matrix possess the capacity to induce HO. However, the process cannot be recapitulated using recombinant proteins without extremely high doses suggesting other components are required for this process. Study of injuries that increase risk for HO, i.e. amputation, hip replacement, elbow fracture, burn, and CNS injury suggests that a likely candidate is traumatic injury of adjacent peripheral nerves. Recent studies suggest neuroinflammation may play a key functional role, by its ability to open the blood-nerve barrier (BNB). Barrier opening is characterized by a change in permeability and is experimentally assessed by the ability of Evans blue dye to enter the endoneurium of peripheral nerves. A combination of BMP and barrier opening is required to activate bone progenitors in the endoneurial compartment. This process is referred to as "neurogenic HO".

Keywords: Bone morphogenetic protein 2; Heterotopic ossification; Nerve injury; Neural osteoprogenitors; Neurogenic HO; Neuroinflammation; Traumatic injury-induced bone formation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Bone Morphogenetic Protein 2 / metabolism
  • Cell Movement / physiology
  • Humans
  • Ossification, Heterotopic / pathology*
  • Peripheral Nervous System / cytology
  • Peripheral Nervous System / metabolism
  • Stem Cells / pathology
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Bone Morphogenetic Protein 2
  • Vascular Endothelial Growth Factor A